Sémaphorines et cancers: État des lieux

4Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Semaphorins, first described as axon guidance molecules, play an essential role in neural development, angiogenesis and immunological response. In 1996, two semaphorin genes, SEMA3B and SEMA3F, were isolated from chromosomal region 3p21.3 believed to contain a tumor suppressor gene based on frequent loss of heterozygosity in lung and breast cancer. Since these first studies, several semaphorins have been involved in tumor progression. Some semaphorins have been proposed to have pro-tumoral properties, whereas others have been shown to have tumor suppressive activity. This review summarizes the most recent data implicating semaphorins in cancers.

Cite

CITATION STYLE

APA

Nasarre, P., Constantin, B., Drabkin, H. A., & Roche, J. (2005). Sémaphorines et cancers: État des lieux. Medecine/Sciences. Elsevier Masson SAS. https://doi.org/10.1051/medsci/2005216-7641

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free